Related Experiment Video
Updated: Aug 7, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Therapeutic potential of RNA interference against cancer
Fumitaka Takeshita1, Takahiro Ochiya
1Section for Studies on Metastasis, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Abstract:
One of the most dramatic events of the past 5 years in the field of molecular biology has been the discovery of RNA interference (RNAi). Although RNAi is an evolutionarily conserved phenomenon for sequence-specific gene silencing in mammalian cells, exogenous small interfering RNA (siRNA) and vector-based short hairpin RNA (shRNA) can also invoke RNAi responses. Both are now not only experimental tools for analyzing gene function but are expected to be excellent avenues for drug target discovery and the emerging class of gene medicine for targeting incurable diseases such as cancer. The success of cancer therapeutic use of RNAi relies on the development of safe and efficacious delivery systems that introduce siRNA and shRNA expression vectors into target tumor cells. For their delivery, a variety of strategies have been used, most of them based on traditional gene therapy delivery systems. In this review, we present siRNA delivery method strategies and discuss the potential of RNAi-based gene therapy in cancer treatment.
Insights
RNA interference (RNAi) is a powerful gene silencing tool. This review explores RNAi-based strategies for delivering small interfering RNA (siRNA) and short hairpin RNA (shRNA) for cancer gene therapy.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- RNA interference (RNAi) is a conserved mechanism for sequence-specific gene silencing.
- Exogenous small interfering RNA (siRNA) and short hairpin RNA (shRNA) leverage RNAi for gene function analysis.
- RNAi holds promise for drug target discovery and gene medicine, particularly for cancer.
Purpose of the Study:
- To review siRNA delivery methods for RNAi-based cancer therapy.
- To discuss the potential of RNAi gene therapy in treating cancer.
Main Methods:
- Review of existing literature on siRNA and shRNA delivery systems.
- Analysis of traditional gene therapy delivery approaches for RNAi applications.
Main Results:
- Various strategies exist for delivering siRNA and shRNA into target cells.
- Current delivery methods often adapt traditional gene therapy systems.
Conclusions:
- Effective delivery systems are crucial for the success of RNAi-based cancer therapeutics.
- RNAi-based gene therapy presents a promising avenue for treating incurable cancers.
More Related Videos
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs
MicroRNAs

